Taiwan Bio Therapeutics Co (ROCO:6892) FCF Margin % : -236.79% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Taiwan Bio Therapeutics Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Taiwan Bio Therapeutics Co's Free Cash Flow for the six months ended in Dec. 2023 was NT$-173.04 Mil. Taiwan Bio Therapeutics Co's Revenue for the six months ended in Dec. 2023 was NT$73.08 Mil. Therefore, Taiwan Bio Therapeutics Co's FCF Margin % for the quarter that ended in Dec. 2023 was -236.79%.

As of today, Taiwan Bio Therapeutics Co's current FCF Yield % is -12.14%.

The historical rank and industry rank for Taiwan Bio Therapeutics Co's FCF Margin % or its related term are showing as below:

ROCO:6892' s FCF Margin % Range Over the Past 10 Years
Min: -861.06 Med: -498.74 Max: -334.37
Current: -334.37

During the past 5 years, the highest FCF Margin % of Taiwan Bio Therapeutics Co was -334.37%. The lowest was -861.06%. And the median was -498.74%.

ROCO:6892's FCF Margin % is ranked worse than
61.57% of 1046 companies
in the Biotechnology industry
Industry Median: -141.025 vs ROCO:6892: -334.37

Taiwan Bio Therapeutics Co FCF Margin % Historical Data

The historical data trend for Taiwan Bio Therapeutics Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiwan Bio Therapeutics Co FCF Margin % Chart

Taiwan Bio Therapeutics Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

-861.06

-498.74

-334.37

Taiwan Bio Therapeutics Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial			-343.93	-363.82	-868.98	-909.77	-236.79

Competitive Comparison of Taiwan Bio Therapeutics Co's FCF Margin %

For the Biotechnology subindustry, Taiwan Bio Therapeutics Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Taiwan Bio Therapeutics Co's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Taiwan Bio Therapeutics Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Taiwan Bio Therapeutics Co's FCF Margin % falls into.

Taiwan Bio Therapeutics Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Taiwan Bio Therapeutics Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-285.782	/	85.47
	=	-334.37 %

Taiwan Bio Therapeutics Co's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-173.043	/	73.078
	=	-236.79 %

Taiwan Bio Therapeutics Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Taiwan Bio Therapeutics Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Taiwan Bio Therapeutics Co (ROCO:6892) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Taiwan Bio Therapeutics Co Ltd (ROCO:6892) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 18, Lane 120, Hu Road, Section 1, 6th Floor, Neihu District, Taipei, TWN

Website

http://www.twbio-thera.com

Taiwan Bio Therapeutics Co Ltd is a regenerative medicine company specializing in the development of new cell medicines. It provides cell product process development and foundry (CDMO/CMO) services.

Taiwan Bio Therapeutics Co (ROCO:6892) Headlines

No Headlines